Norway vs Tajikistan: Immunization, Hib3
Norway
97.0%
in 2024
Tajikistan
97.0%
in 2024
Norway rank
29th
Tajikistan rank
29th
Immunization, Hib3 over time
- Norway
- Tajikistan
How they compare
Norway currently reports 97.0% against 97.0% in Tajikistan, a difference of 0.0%.
The two have swapped places 3 times across 17 shared years of data; in 2008 it was Norway ahead.
Norway ranks 29th and Tajikistan ranks 29th of 191 countries.
Across the 3 decades both report, Norway averaged higher in 1 and Tajikistan in 1.
Head to head by decade
| Decade | Norway | Tajikistan | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 94.5% | 69.5% | 25.0% | Norway |
| 2010s | 95.3% | 95.9% | 0.6% | Tajikistan |
| 2020s | 96.8% | 96.8% | 0.0% | — |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher immunization, hib3, Norway or Tajikistan?
- Norway, at 97.0% against 97.0% in Tajikistan as of 2024.
- What is the difference in immunization, hib3 between Norway and Tajikistan?
- 0.0%, with Norway ahead.
- How many years of comparable data are there for Norway and Tajikistan?
- 17 years are reported by both, from 2008 to 2024.
- How do Norway and Tajikistan rank globally for immunization, hib3?
- Norway ranks 29th and Tajikistan ranks 29th of 191 countries.
- Where does this data come from?
- WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/), published as Immunization, Hib3 (% of children ages 12-23 months). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Child immunization, Hib3, measures the percentage of children ages 12-23 months who received Hib3 vaccinations before 12 months or at any time before the survey. A child is considered adequately immunized against Hib3 after receiving three doses of Haemophilus influenzae type b vaccine.